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hope that enlightened editors will take up the challenge; the lead
must come from an established, prestigious journal that can afford
to be choosy.
Conclusion
Publication bias is endemic and will remain so as long as the
sample sizes commonly used in research are too small and the
methods used to assess adequacy of sample size are deficient.
Assessment by a priori criteria-in particular, systematic peer
review at the planning stage-would result in a much tighter
measure of control over the quality of published work, with the
prospect of improvement in study design in general and statistical
power in particular.
I thank several colleagues, especially Dr Edward C Coles and the BMJ
editorial team and the referee, for constructive comments.
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Medicine and the Media
AT THE ANNUAL scientific meeting of the British Paediatric
fkAssociation last year the prize for the best paper presented by a
young paediatrician went to a member of a research group from
Oxford. Papers offered for the annual meeting are examined by the
association's academic board not only for their scientific worth but
also for adherence to ethical standards. This paper, later published
in the Lancet,I has now been condemned by certain sections of the
press and by a group ofmembers of parliament. What was the work
so condemned?
Preterm infants of low birth weight live at considerable risk,
particularly of cardiorespiratory failure, and the risk is increased if
they have to undergo an operation. Clinical experience suggested
that deep anaesthesia and narcotic analgesics would increase the
risk. That and the belief that such infants have a poor perception of
pain because of lack of myelinisation in the central nervous system
led to the conventional practice of anaesthesia with nitrous oxide
and muscle relaxants combined with artificial ventilation. In a study
of40 published reports the Oxford team found that three quarters of
newborn babies undergoing surgical ligation of patent ductus
arteriosus had received muscle relaxants alone or with nitrous oxide.
In the preterm infant with a poor or absent ability to cry it
is difficult to tell clinically whether pain and stress are being
experienced, but newer biochemical methods that detect hormones
and intermediary metabolites associated with stress now make the
assessment of stress more possible and prompted a re-examination
of the problem by the Oxford team. The team wanted to find out
whether adding a little narcotic analgesic to the accepted anaesthetic
regimen might prove beneficial rather than harmful. Using these
metabolic methods, they therefore compared the response to
surgical ligation of patent ductus arteriosus carried out under the
conventional regimen with and without the narcotic analgesic
fentanyl. The possibility that fentanyl might adversely affect
respiration and circulation postoperatively was also studied.
A randomised trial was designed with help from the National
Perinatal Epidemiology Unit in Oxford to ensure that the results
were statistically valid and that a meaningful result would be
recognised as soon as possible. After only eight babies in each group
had been operated on the results showed that the new regimen was
significantly superior to the old not only in reducing the stress
response estimated biochemically but also in improving the
postoperative state. Thus for the first time good scientific evidence
was produced of the need to provide deeper anaesthesia during
operations on these tiny infants.
This research was commended by the distinguished American
paediatrician Dr William Silverman, author ofthe widely acclaimed
bookHuman Experimentation: A GuidedStep Into the Unknown.2 He
wrote that the Oxford workers "deserve a loud vote ofthanks for the
ethically sound effort to subject to a rigorous test opinion based on
long standing practice. And their call for further study should
not fall on deaf ears. It is indeed urgent to determine the
pathophysiological consequences of unrelieved pain and suffering
inflicted during everyday care ofnewborn babies."
Members of the British Paediatric Association were thus amazed
and the doctors who had done the work bewildered and distressed
when after a distorted report in the Daily Mail entitled, "Pain-killer
shock in babies' operations" (8 July) this work became the subject
of a condemnatory "press release: for immediate publication"
issued by some members of parliament forming the All Party
Parliamentary Pro-Life Group. The Lancet article appeared in
January, the story in the Daily Mail in July, and the press release
from the members of parliament in August. The press release
was entitled "Inhumane baby operations slammed" and the first
paragraph stated:
"Fourteen members of parliament have demanded an inquiry
into trials in which sixteen premature babies were given open heart
surgery, eight ofthem without the use ofpain killers to test whether
or not the babies could experience pain."
The press release then said that the General Medical Council was
being asked to investigate these trials with a view to bringing those
responsible before its disciplinary committee. It continued:
"In a statement Sir Bernard Braine said:
'The trials seemed to us to be even more barbarous when one
considers that the babies being tested for pain were given curare, a
paralysing drug, so that they would have been unable to kick or
struggle even if they were in agony, the obvious intention being to
keep them immobile at all costs throughout the operation. Apart
from this they were given only nitrous oxide (laughing gas)."'
Implying misleadingly that wisdom acquired from the research
existed before it was carried out the statement went on:
"Not surprisingly post-operatively they fared far worse than the
eight babies who were given pain killers. Two of the disadvantaged
babies suffered from hypotension, two showed poor peripheral
circulation-both of which can be indications of shock which most
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certainly could have resulted from extreme pain; two others
suffered from brain haemorrhage-whereas none of those babies
given pain killing drugs experienced any such ill effects."
Taken up&by the national press this press release resulted in
headings such as: "Barbaric! MPs' anger over baby operations. No
painkiler drugs for tiny heart patients used in research trial" (Daily
Express, 5 August); "Babies in 'barbaric' pain trials" (Universe,
7 August); "MPs attack 'paralysing' pain tests on babies" (Today,
5 August); "MPs concerned by surgery on babies" (The Times,
5 August); and "Baby 'pain trials' row (Northern Echo, 5 August).
Death or lifelong disability are unfortunately the common fate of
preterm infants of low birthweight, particularly those further
compromised by additional congenital abnormalities as with the
babies studied in this research. Every day paediatricians are having
to take difficult decisions on whether, with a view to improving
the chances of preterm infants, uncomfortable or distressing
procedures have to be imposed on them. Only from research can
improved practice emerge, and the fortunate outcome of this
Oxford research was that it showed that not only did a narcotic
analgesic relieve short term stress but also-contrary to so much
contemporary belief-it improved rather than compromised the
postoperative state.
Research on preterm newborn infants raises difficult ethical
issues. The ethical debate legitimately extends beyond paedia-
tricians and doctors, but it is irresponsible for laymen to presume to
interpret medical information when they are not competent to do
this. The press release of the members of parliament used
intemporate language and made many mistakes: the Oxford trial
was described as one in which premature babies were "given open
heart. surgery" when open heart surgery was not performed; the
surgery was said to be performed "without the use of pain killers"
when all the babies were anaesthetised with nitrous oxide; the trial
was said to "test whether or not the babies could experience pain"
when the object was to ascertain whether accepted procedures were
causing previously undetected stress; the research was called
"barbarous" when it was caring; and the press release said that
curare was given so that the babies "would have been unable to kick
or struggle even if they were in agony, the obvious intention being to
keep them immobile at all costs throughout the operation" when the
function of the curare was to enable artificial respiration to be
carried out during the operation.
These doctors' research deserved the highest commendation. It
was done with the written informed consent of the parents, was
designed to reduce suffering in newborn infants, was of high
scientific standard, was completely ethical, meant that eight out of
the 16 babies in the trial received an improved treatment, and will
confer benefit on many babies yet unborn. We are disturbed that
members of parliament should use their positioh to stigmatise
valuable medical research and the doctors who carried it out by
issuing an inaccurate and defamatory press statement and that the
press should so misrepresent and sensationalise what was done.
Public retraction of these statements and public apologies to the
doctors concerned seem the least that should be done to correct
these misleading pronouncements. Perhaps, too, the All Party
Parliamentary Pro-Life Group will acknowledge the essential part
that such research has played in improving the prospects of life
of preterm babies.-j o FORFAR, president, British Paediatric
Association, and A G M CAMPBELL, chairman, British Paediatric
Association Ethics Advisory Committee, London.
1 Anand KJS, Sippell WG, Aynsley-Green A. Randomised trial of fentanyl anaesthesia in preterm
babies undergoing surgery: effects on the stress response. Lancet 1987;i:2438.
2 Silverman WA. Analgesia and anaesthesia in newborn infants. Lancet 1987;i: 1090.
TTHE GOVERNMENT'S initial cagpaign in the mass media on
teacquired immune deficiency syndrome (AIDS) featured
tombstones and sombre imagery. The latest phase, launched on
2 September, consists of a £5m initiative that focuses on the dangers
of drug users who share infected injecting equipment spreading the
human immunodeficiency virus (HIV). The new campaign is
deliberately designed to shock. One warning depicts a body in a
plastic bag. A poster shows a bloodstained syringe.
As one would expect with any campaign related to such sensitive
topics as intravenous drug use and AIDS it has received a mixed
response. The press has been generally mildly favourable, though
some people have criticised the style as "over the top" or even
offensive. Some were upset by one of the campaign's more
memorable slogans: "It only takes one prick to give you AIDS."
The potential seriousness of the rising AIDS epidemic cannot be
exaggerated, and the government is to be congratulated for
responding to this phenomenon with commitment and vigour.
AIDS is so new that it is uncertain which are the most fruitful forms
ofpreventive action. There are, however, some grounds for urging a
degree, not of inaction, but of caution.
Health education is fraught with problems. People are often
chronically irrational, even perverse, and indulge in risky or
unhealthy pursuits for a confusing and conflicting variety of
reasons. Past health promotion exercises that have attempted to
deter illegal drug use or problematic drinking have produced
disappointing results-often they have been ineffective or even
counterproductive.'-7 Even in relation to cigarette smoking (which
has declined) the effect of health education is unclear.8 Available
evidence has led many authorities to regard expensive mass
media campaigns as fruitless. The Advisory Council on the
Misuse of Drugs emphasised this view in its report on Prevention.'
.........;....... ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~~~~~~~ ......
Notwithstanding such objections a national antidrug campaign was
launched in 1985 that in effect adopted precisely the type of strategy
which the advisory council had warned against. The Health
Education Council (for England and Wales) declined to participate
in such a venture, and its subsequent replacement by the Health
Education Authority was regarded by some observers as, in part at
least, the penalty for displaying such independence. It is difficult to
find anyone-clinicians, counsellors, educationalists, or researchers
-who has a positive attitude to that "Heroin screws you up"
Thereare pwerfuljusifhication for% ^any governmevntmtorbei
wore about.....................................ileadruguseand even more worried. abu AD.
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Attempts must NJbe madeOto devis efetveuain othrtye
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of preventive strategy. Even so, a word of warning is needed. Drug
education and health promotion are imperfect technologies that
should be used with care and if possible should also be assessed.
High profile mass media campaigns are politically attractive because
they are conspicuous tokens of concern and commitment. The
question is "do they work?" During the past 20 years few costly
health promotion campaigns in Britain have been properly
evaluated. This is unacceptable.
Moreover, attempts to question the effectiveness of such
exercises have invariably provoked not a determination to evaluate
future ventures but genuine surprise and annoyance. Health
education is widely perceived (rightly) as worthy and (wrongly) as
totally effective. Experience suggests that individual campaigns are
unlikely to deter young people from using illegal drugs and that
shock tactics have been unproductive. We are surprised that this
new campaign adopts such shock tactics. In addition, while the
message on AIDS is clear there is an implied "heroin screws you up"3
theme that may alienate rather than persuade young heroin users.
We hope that this campaign and its successors are effective. We
CLIVE JERMAINE IS 21, intelligent, mature, self assured,
quick thinking, verbally fluent, and down to earth. When he
was 15 he developed a spinal tumour and had an operation that
rendered him paraplegic. He was told that he had months or a few
years to live, and the consequence was that he wrote a play for
television, TheBest Years ofYourLife, which was first shown in May
1986 and repeated on 2 September (BBC2). The next evening there
was a documentary about Clive; his play, his thoughts and
experiences, and the media and public reaction to the play.
The play was about a young footballer who suffered from the
same illness andwho died. He lived with his father and slightly older
brother, their mother having been killed when the brothers were
young. The brother tried to help him, but the father took refuge in
drink. In real life Clive's own father had opted out after two years,
and he was closest to his grandmother. She had given him courage
and strength and had encouraged him while he was writing the play,
but she had then died oflaryngeal cancer.
The play was a well written and moving story. It showed the
emotional difficulties of the family and emphasised the need of the
patient with cancer for support and understanding. It received
hope, too, that this and subsequent ventures will be objectively and
competently evaluated. The results should also be made freely
available and used to guide future policy. The full proposed AIDS
campaign when completed will have cost £20m. It would be a
tragedy if the only beneficiaries are advertising executives.-
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critical acclaim, and over 300 people wrote to Clive to express their
appreciation. The story of the play and of Clive's own disease was
featured on television news, and he was interviewed on Breakfast
Television by Selina Scott: "So you're faced with the prospect of
dying very soon. How do you stop yourself sinking down into
depression?" Interviewed for the documentary, Clive admitted that
he and his family had on occasions found the media questions and
voyeurism harrowing, though on television he never lost his
composure. One episode that had a deep effect on him was his
grandmother's death and the fact that the next day, in the middle of
his grief, people in the street were singing and the world had
not noticed-"Once you die you're nothing. The world goes on
regardless."
When he was asked why he wrote the play and agreed to appear in
the documentary he had two answers. Firstly, he wished to educate
people about cancer and the needs of people who suffer from it and
to help do away with "the taboo." Secondly, he felt a need to achieve
in the life remaining to him-to do something to be remembered by.
He has had much success with both objectives.-DOUG ADDY,
consultant paediatrician, Birmingham.
